Oral Presentations

Axel Graewingholt, MD; Julie Shisler; Regina-Maria Schwanitz-Graewingholt, MD; James Pike; Jonathan Go; Martin Mishkov; Jeffrey Worth Hoffmeister, MD,MS

Real World Use of Artificial Intelligence Risk Scores to Identify Women at High Risk for Breast Cancer with Subanalyses Based on Histopathology and Time of Detection

Oral Presentations

Chirag R. Parghi, MD,MBA; Avishkar Sharma, MD; Jeffrey Worth Hoffmeister, MD, MS; Zi Zhang, MD; Ryan Karlson Lee, MD, MBA; Jonathan Go; Wei Zhang; Jennifer Pantleo, BSN, RN

Artificial Intelligence Assessment of Breast Arterial Calcifications on Mammography in a Large Screening Population

Tom Cappas MBA, MS RT (R)(MR)

COO, Midstate Radiology Associates, LLC.

“With PowerLook Density Assessment, our density assessments have become more standardized and uniform, which has more than doubled our utilization of screening breast ultrasound and ultimately helps us identify which women would benefit from supplemental screening. And with ProFound AI, our team is overall more confident and efficient in reading even the most complex mammography cases."

Meghan Musser, DO

Medical Director for Breast Imaging, Kettering Health

“Other AI technologies simply do not deliver the level of performance, speed and accuracy that ProFound AI offers. Additionally, a unique value of ProFound AI is its ability to detect small or subtle lesions, such as invasive lobular cancers. I believe that every woman deserves to have access to this technology, as it can be a critical tool in overcoming healthcare disparities.”

Angela Fried, MD

Director of Breast Imaging, SimonMed Imaging

“AI has gotten very accurate, and our techs are able to take that information and plug it into the risk model without bothering a RAD on what density they should put. We can very quickly add information to our reports and give information to patients and their physician to know if they should be coming in for additional screening. It gives patients peace of mind when they have very dense breast tissue or to identify cancer earlier.”

Joshua A. Nepute, MD

Radiologist, IU Health Frankfort, IU Health Arnett, IU Health White Memorial

“This leading-edge algorithm was designed to provide physicians with crucial information about a woman’s short-term risk of being diagnosed with breast cancer, so that they may further personalize her screening and surveillance plan. This may include screening frequency adjustment, supplemental imaging, genetic testing and/or risk reduction strategies.”

Detection

Density Assessment

Risk Evaluation

Detection

Density Assessment

Risk Evaluation

Heart Health

"Coming Soon"